Ignite Creation Date:
2024-05-06 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05331326
Status:
UNKNOWN
Last Update Posted:
2022-04-15
First Post:
2022-04-08
Brief Title:
A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-08
First Submit QC Date:
April 8 2022
Study First Post Date:
2022-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-08
Last Update Post Date:
2022-04-15
Last Update Post Date Type:
ACTUAL